CHICAGO, April 2, 2019 /PRNewswire/ -- According to the new market research report "Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024", published by MarketsandMarkets, the global Live Cell Encapsulation Market is projected to reach USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%.
The major factors driving the growth of the Live Cell Encapsulation Market are the rising public awareness related to the clinical role of encapsulated cells in disease management, increasing public-private investments to support product development, and the rising adoption of novel drug delivery systems for disease treatment.
Based on manufacturing technique, the Live Cell Encapsulation Market is segmented into . The instruments segment is expected to account for the largest share of the Live Cell Encapsulation Market in 2019. The increasing adoption due to the procedural benefits (such as simple process, product biocompatibility, and low particle size distribution) are the major factors driving the growth of this market segment.
Based on polymer type, the Live Cell Encapsulation Market is segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl methacrylate), chitosan, siliceous encapsulates, cellulose sulfate, PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers. The alginate segment is expected to grow at the highest CAGR during the forecast period primarily due to the procedural benefits such as uniform cell structures and high mechanical stability.
Drug delivery to account for the largest share of the Live Cell Encapsulation Market, by application, in 2018
Based on end user, the Live Cell Encapsulation Market is segmented into drug delivery, regenerative medicine, cell transplantation, probiotics, and research. Drug delivery are estimated to be the largest application of live cell encapsulation, and this trend is expected to continue during the forecast period. The large share of this application segment can be attributed to the ongoing technological advancements in the field of cell encapsulation and increased product affordability, and usage of biocompatible immobilization or isolation systems.
The Live Cell Encapsulation Market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America is estimated to be the largest regional market for live cell encapsulation in 2019 majorly due to the increasing clinical data for the efficacy of the cell encapsulation technique and the rising adoption of cell encapsulation techniques among medical professionals.
Die wallstreet:online AG wendet sich nur an gut informierte und erfahrene Anleger, die nicht auf eine Anlageberatung angewiesen sind. Es werden keine Beratungsdienstleistungen erbracht, eine Aufklärung über angebotenen Anlagen erfolgt ausschließlich in Form von standardisierten Informationsunterlagen.
Ich bin mit der Geltung der Nutzungsbedingungen einverstanden.
Ich willige ein, daß meine Daten (Name, Anschrift, E-Mail) zum Zwecke der Depoteröffnung von wallstreet:online AG an die wallstreet:online capital AG (FondsDISCOUNT.de) übermittelt werden.
Also in Industry News
NEW YORK (GenomeWeb) – Genetic factors that contribute to a highly heritable developmental condition called Hirschsprung's disease include a complex suite of risk variants, ranging from common polymorphisms in non-coding elements to rarer coding variants and copy number variants (CNVs), according to new research from investigators at Johns Hopkins University, the University of Washington, the Broad Institute, and New York University.
"In our study, we found that the risk of the complex phenotype...
In the publication of this article , there is an error in one of the contributing author names.
The error: ‘Jalal Abdolali Zade’
Should instead read: ‘Jalal Abdolalizadeh’
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, prov...
Date: Tuesday, 11 June, 2019
Time: 09:30 – 13:00
Place: Fèlix Serratosa, Parc Cientific de Barcelona (PCB)
This short workshop will describe many aspects of heterologous expression in E.coli, from choice of construct design through to methods to improve the levels of soluble expression and options for co-expression. In addition, it will also address expression in eukaryotic hosts, including secreted proteins and ECDs, and options for co-expression.
The workshop will finish with a discussion an...